Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement

Triple-negative breast cancer (TNBC) is the most violent class of tumor and accounts for 20–24% of total breast carcinoma, in which frequently rare mutation occurs in high frequency. The poor prognosis, recurrence, and metastasis in the brain, heart, liver and lungs decline the lifespan of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Farheen, Jabeen, Hosmane, Narayan S., Zhao, Ruibo, Zhao, Qingwei, Iqbal, M. Zubair, Kong, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576993/
https://www.ncbi.nlm.nih.gov/pubmed/36267139
http://dx.doi.org/10.1016/j.mtbio.2022.100450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576993/
https://www.ncbi.nlm.nih.gov/pubmed/36267139
http://dx.doi.org/10.1016/j.mtbio.2022.100450

Ejemplares similares